A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Researchers said future study should focus on how chemo specifically causes nerve pain, and on developing therapies that can protect cancer patients who are receiving the lifesaving treatment.

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

VMPL Pune Maharashtra [India] January 24 Living with chronic spine and back pain can be tough making everyday tasks difficult ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

Our goal is to relieve pain and help patients regain function without surgery. We create personalized care plans to address each ...